Aridis Pharmaceuticals

ARDS

0.00010.00% ( 0.0000 )

Delay Trading: Jul 30, 09:30:00 (EDT)

Q3 FY2023 Earnings

Financial report interval: 2023.06.30 - 2023.09.30

Preview: Aridis Pharmaceuticals(ARDS) predict that the Revenue is 417 K (+4.51%), Miss estimate;the EBIT is -869 K (+88.28%), Beat estimate;the EPS is 0 (+100%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueMiss expectations

0.00B4.51%

0.00B275.94%

-0.00B271.43%

EBITExceed expectations

-0.00B88.28%

-0.00B43.34%

+0.00B44.94%

EPSExceed expectations

0100.00%

-0.178.72%

+0.100021.28%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD